2NDO | pdb_00002ndo

Structure of EcDsbA-sulfonamide1 complex


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 200 
  • Conformers Submitted: 10 
  • Selection Criteria: structures with the lowest energy 

wwPDB Validation 3D Report Full Report

Validation slider image for 2NDO

This is version 1.2 of the entry. See complete history

Literature

Determination of ligand binding modes in weak protein-ligand complexes using sparse NMR data.

Mohanty, B.Williams, M.L.Doak, B.C.Vazirani, M.Ilyichova, O.Wang, G.Bermel, W.Simpson, J.S.Chalmers, D.K.King, G.F.Mobli, M.Scanlon, M.J.

(2016) J Biomol NMR 66: 195-208

  • DOI: https://doi.org/10.1007/s10858-016-0067-4
  • Primary Citation Related Structures: 
    2NDO, 4ZIJ

  • PubMed Abstract: 

    We describe a general approach to determine the binding pose of small molecules in weakly bound protein-ligand complexes by deriving distance constraints between the ligand and methyl groups from all methyl-containing residues of the protein. We demonstrate that using a single sample, which can be prepared without the use of expensive precursors, it is possible to generate high-resolution data rapidly and obtain the resonance assignments of Ile, Leu, Val, Ala and Thr methyl groups using triple resonance scalar correlation data. The same sample may be used to obtain Met ε CH 3 assignments using NOESY-based methods, although the superior sensitivity of NOESY using [U- 13 C, 15 N]-labeled protein makes the use of this second sample more efficient. We describe a structural model for a weakly binding ligand bound to its target protein, DsbA, derived from intermolecular methyl-to-ligand nuclear Overhauser enhancements, and demonstrate that the ability to assign all methyl resonances in the spectrum is essential to derive an accurate model of the structure. Once the methyl assignments have been obtained, this approach provides a rapid means to generate structural models for weakly bound protein-ligand complexes. Such weak complexes are often found at the beginning of programs of fragment based drug design and can be challenging to characterize using X-ray crystallography.


  • Organizational Affiliation
    • Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC, 3052, Australia.

Macromolecule Content 

  • Total Structure Weight: 21.56 kDa 
  • Atom Count: 1,508 
  • Modeled Residue Count: 189 
  • Deposited Residue Count: 189 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Thiol:disulfide interchange protein DsbA189Escherichia coli K-12Mutation(s): 0 
Gene Names: dsbAdsfppfAb3860JW3832
UniProt
Find proteins for P0AEG4 (Escherichia coli (strain K12))
Explore P0AEG4 
Go to UniProtKB:  P0AEG4
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP0AEG4
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
SFQ

Query on SFQ



Download:Ideal Coordinates CCD File
B [auth A]2-{[(4-iodophenyl)sulfonyl]amino}benzoic acid
C13 H10 I N O4 S
PLJIQKJMJAHNRG-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 200 
  • Conformers Submitted: 10 
  • Selection Criteria: structures with the lowest energy 

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2017-02-08
    Type: Initial release
  • Version 1.1: 2023-06-14
    Changes: Data collection, Database references, Derived calculations, Other
  • Version 1.2: 2024-05-15
    Changes: Data collection, Database references